Security key
G3855L106
GH Research PLC - Ordinary Shares, nominal value $0.025 per share (GHRS)
CUSIP: G3855L106
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Ordinary Shares, nominal value $0.025 per share
- Total 13F shares
- 43,554,151
- Total 13F value
- $530,925,463
- Share change
- +923,966
- SEC-reported price per share
- $12.19
- Number of holders
- 37
- Value change
- +$12,435,267
- Number of buys
- 18
- Number of sells
- 16
- Shares outstanding
- 61,857,977
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
37
Top holders
10
GHRS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
GH Research PLC SEC filings
GH Research PLC company facts
Broader feeds
Reporting periods
Holder history for CUSIP G3855L106
Recent filing periods:
Ownership snapshot
Top reported holders of GHRS - GH Research PLC - Ordinary Shares, nominal value $0.025 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BIOTECHNOLOGY VALUE FUND L P
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
15/15
Latest evidence
30 Jun 2025
13D/G
13F
Lead comparable stake: 14%
13D/G row: BIOTECHNOLOGY VALUE FUND L P
Showing 1-6 of 15 holder rows.
Quick read
BIOTECHNOLOGY VALUE FUND L P leads the comparable SEC ownership view at 14%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BIOTECHNOLOGY VALUE FUND L P's linked filing trail.
Comparable ownership
Top 5
BIOTECHNOLOGY VALUE FUND L P
14%
RA CAPITAL MANAGEMENT, L.P.
12%
RTW INVESTMENTS, LP
8.9%
FMR LLC
8.2%
BVF INC/IL
14%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P |
13D/G
BVF PARTNERS L P/IL
|
14%
|
$84,128,095
8,827,712 shares
|
$0 | 31 Mar 2025 |
| RA CAPITAL MANAGEMENT, L.P. |
13D/G
13F
Company
|
12%
|
$123,210,987
7,676,697 shares
|
+$11,749,386 | 30 Jun 2025 |
| RTW INVESTMENTS, LP |
13F
13D/G
Company
|
8.9%
from 13D/G
|
$60,662,452
5,499,769 shares
|
— | 31 Mar 2025 |
| FMR LLC |
13D/G
13F
Company
|
8.2%
|
$81,728,927
5,092,145 shares
|
+$13,523,168 | 30 Jun 2025 |
| BVF INC/IL |
13F
Company
|
14%
|
$97,369,663
8,827,712 shares
|
— | 31 Mar 2025 |
| Lynx1 Capital Management LP |
13F
Company
|
10%
|
$71,076,658
6,443,940 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
37
Shares
43,554,151
Rows available
37
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
35
Q2 2025 holders
37
Holder diff
2
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend